Assessment of Return to Baseline Urinary and Sexual Function Following Primary Focal Cryotherapy for Nonmetastatic Prostate Cancer.

Saved in:
Bibliographic Details
Title: Assessment of Return to Baseline Urinary and Sexual Function Following Primary Focal Cryotherapy for Nonmetastatic Prostate Cancer.
Authors: Shah TT; Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; Division of Surgery and Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospital (UCLH), UK. Electronic address: t.shah@imperial.ac.uk., Peters M; Department of Radiotherapy, University Medical Centre, Utrecht, The Netherlands., Miah S; Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; Division of Surgery and Interventional Sciences, University College London, London, UK., Eldred-Evans D; Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK., Yap T; Department of Urology, Guy's Hospital, Great Maze Pond, London, UK., Hosking-Jervis F; Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK., Dudderidge T; Department of Urology, University Hospital Southampton NHS Trust, Southampton, UK., Hindley RG; Department of Urology, University College London Hospital (UCLH), UK; Department of Urology, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK., McCracken S; Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Greene D; Department of Urology, Sunderland Royal Hospital, Sunderland, UK., Nigam R; Department of Urology, Royal Surrey County Hospital NHS Trust, UK., Valerio M; Department of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Winkler M; Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Virdi J; Department of Urology, The Princess Alexandra Hospital NHS Trust, Harlow, UK., Arya M; Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; Division of Surgery and Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospital (UCLH), UK; Department of Urology, The Princess Alexandra Hospital NHS Trust, Harlow, UK., Ahmed HU; Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Minhas S; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Source: European urology focus [Eur Urol Focus] 2021 Mar; Vol. 7 (2), pp. 301-308. Date of Electronic Publication: 2019 Oct 05.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101665661 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-4569 (Electronic) Linking ISSN: 24054569 NLM ISO Abbreviation: Eur Urol Focus Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2405-4569
DOI:10.1016/j.euf.2019.09.004